Naproxen Sodium | CAS 26159-34-2 - Request Quote
Naproxen Sodium
| SZ CAT No: | SZ-N007037 |
| CAS No | 26159-34-2 |
| Mol.F. | C14H13O3 : Na |
| Mol.Wt. | 229.3 : 23.0 |
| Inv. Status | In Stock |
| Rel. CAS No | 22204-53-1 (free base) ; 57351-39-0 (K salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Naproxen Sodium is chemically Sodium (S)-2-(6-methoxynaphthalen-2-yl)propanoate. Naproxen Sodium is supplied with detailed characterization data compliant with regulatory guideline. Naproxen Sodium can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Naproxen.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 26159-34-2
Purchase 26159-34-2
Order 26159-34-2
Enquire 26159-34-2
price of 26159-34-2
26159-34-2 Supplier
26159-34-2 Manufacturer
26159-34-2 Exporter
buy high quality Naproxen Sodium
Purchase Naproxen Sodium
Naproxen Sodium suppliers
Naproxen Sodium manufacturers
Naproxen Sodium price
Order Naproxen Sodium
Enquire Naproxen Sodium
Naproxen Sodium cost
Naproxen Sodium Supplier
Naproxen Sodium Distributor
Naproxen Sodium for Method Validation
Naproxen Reference Standard
Naproxen Sodium for ANDA Filing
Naproxen Sodium for Forced Degradation Studies
Naproxen Sodium Identification Standards
Naproxen Sodium for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.